Info
A. Epidemiology
- Rate is nearly 2% of pregnancies in USA
- Second major cause of maternal mortality in USA
- Major cause of maternal mortality in first trimester
B. Risk Factors
- Usually occurs in women with impaired fallopian tube function
- High Risk (>5 fold increase)
- Tubule surgery
- Sterilization
- Previous Ectopic Pregnancy
- In utero exposure to diethylstilbestrol (DES)
- Use of intrauterine device (IUD) for contraception
- Moderate Risk (>2 fold increase)
- Infertility (including due to gynecologic infections)
- Previous gynecologic infections
- Multiple sex partners
- Somewhat Increased risk
- Smoking
- Pelvic Surgery
- Vaginal Douching
C. Symptoms and Signs
- Abdominal Pain and/or Tenderness >75%
- Pelvic Pain and/or Flank Pain
- Isthmic ectopics present early
- However, ampullary ectopics present late
- Amenorrhea
- Pain radiating to shoulder
- Cervical motion tenderness ~67%
- Palpable adnexal mass ~50%
- Syncope
- Shock (usually following rupture)
D. Diagnosis [3]
- High suspicion in all persons at moderate to high risk
- Screening by measuring ß-hCG with transvaginal ultrasound
- Sensitivity ~85%
- Specificity 100%
- ß-HCG (human chorionic gonadogropin)
- Note that in normal pregnancy, ß-hCG levels double every ~2 days
- If quantitative ß-hCG is >1500 then should see gestational sac on vaginal ultrasound
- If quantitative ß-hCG >5000 then should see sac on abdominal ultrasound
- Progesterone levels are useful as single measurement
- Progesterone level >25ng/mL excludes ectopic pregnancy by >97%
- Pelvic or transvaginal ultrasound
- Rule out intrauterine pregnancy
- Confirm diagnosis of ectopic pregnancy
E. Treatment
- Medical and Surgical treatment modalities are available
- Surgical
- Laparoscopy is mainstay
- Oophorectomy / Salpingectomy
- Medical [3]
- Methotrexate 20mg single dose IM if stable with no acute abdomen
- About 20% of women will require additional cycle of methotrexate
- RU486 (Mifepristone) - close to approved in USA [2]
References
- Pisarska MD, Carson SA, Buster JE. 1998. Lancet. 351(9109):1115
- Spitz IM, Bardin CW, Benoton L, Robbins A. 1998. NEJM. 338(18):1241
- Lipscomb GH, Stovall TG, Ling FW. 2000. NEJM. 343(18):1325